About EKR Therapeutics
EKR Therapeutics is a company based in Bedminster (United States) founded in 2005 by Cathy Kerzner and Richard DeSimone was acquired by Cornerstone Therapeutics in May 2012.. EKR Therapeutics has raised $63 million across 3 funding rounds from investors including Cornerstone Therapeutics, GE Healthcare Equipment Finance and Turmeric Acquisition Corp.
- Headquarter Bedminster, United States
- Founders Cathy Kerzner, Richard DeSimone
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$63 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series C
Mar 10, 2008
-
Investors
Cornerstone Therapeutics
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Cornerstone Therapeutics
(May 14, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EKR Therapeutics
EKR Therapeutics has successfully raised a total of $63M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in March 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $50.0M
-
First Round
First Round
(15 Aug 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2008 | Amount | Debt – Conventional - EKR Therapeutics | Valuation |
investors |
|
| Mar, 2008 | Amount | Series C - EKR Therapeutics | Valuation | MPM Capital , LLR Partners | |
| Aug, 2007 | Amount | Series C - EKR Therapeutics | Valuation | Quaker Partners Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EKR Therapeutics
EKR Therapeutics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Cornerstone Therapeutics, GE Healthcare Equipment Finance and Turmeric Acquisition Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing in technology and healthcare businesses for growth capital.
|
Founded Year | Domain | Location | |
|
Investment firm focusing on lower-middle market growth, healthcare, and various strategies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EKR Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EKR Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ekr Therapeutics Comparisons
Competitors of EKR Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about EKR Therapeutics
When was EKR Therapeutics founded?
EKR Therapeutics was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is EKR Therapeutics located?
EKR Therapeutics is headquartered in Bedminster, United States. It is registered at Bedminster, New Jersey, United States.
Who is the current CEO of EKR Therapeutics?
John Bailye is the current CEO of EKR Therapeutics.
Is EKR Therapeutics a funded company?
EKR Therapeutics is a funded company, having raised a total of $63M across 3 funding rounds to date. The company's 1st funding round was a Series C of $13M, raised on Aug 15, 2007.
What does EKR Therapeutics do?
EKR Therapeutics was founded in 2005 and is located in Bedminster, United States. Operations in the specialty pharmaceutical sector involve the acquisition, development, and commercialization of prescription products focused on oncology supportive care. Therapeutic areas addressed include oral mucositis, stomatitis, dry mouth, nutritional support, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea.
Who are EKR Therapeutics's investors?
EKR Therapeutics has 7 investors. Key investors include Cornerstone Therapeutics, GE Healthcare Equipment Finance, Turmeric Acquisition Corp, LLR Partners, and NewSpring Capital.